It has been proven in vivo that glabridin can protect hygromycin-resistant BDF1 transgenic mice against LPS-induced sepsis by reducing the production of various inflammatory mediators such as TNF-α and NO [7] . The gene discussed is TNF; the disease is Sepsis.